Phase 2 Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are willing and able to sign a consent form agreeing to take part in the study.
- People who are 18 years of age or older.
- People who have been diagnosed with non-small cell lung cancer (a type of lung cancer) confirmed by a tissue or cell sample from a needle biopsy, and whose cancer is at stage II to IIIB (with certain lymph node involvement), confirmed by scans such as CT or PET-CT.
- People whose general health and ability to carry out daily activities is rated at 0 or 1 on a standard scale used by doctors (meaning fully active or able to do light activity).
- People who are expected to live for at least 12 weeks.
- People who have at least one area of cancer that can be measured on scans, according to standard medical guidelines.
- People whose liver, kidneys, blood, and other major organs are functioning well enough to take part.
- People whose lung function is strong enough to safely undergo surgery.
- People whose cancer has not spread to other parts of the body.
- Women who could become pregnant must agree to use effective contraception throughout the study and for at least 120 days after the last dose of chemotherapy or immunotherapy (whichever comes later), and must have a negative pregnancy test within 7 days before joining.
- Men who have not had a sterilisation procedure must agree to use effective contraception throughout the study and for at least 120 days after the last dose of chemotherapy or immunotherapy (whichever comes later).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have already received any cancer treatment for a thymic epithelial tumour (a type of tumour in the chest), including surgery, radiation, chemotherapy, targeted therapy, or experimental treatments.
- People who have any unstable ongoing health conditions, such as an active infection, uncontrolled high blood pressure, unstable chest pain, chest pain that started in the last three months, moderate-to-severe heart failure, a heart attack in the past six months, a serious irregular heartbeat requiring medication, or significant liver, kidney, or metabolic disease.
- People who have an active or suspected autoimmune disease, or a nervous system condition related to cancer that requires treatment affecting the whole body.
- People who are allergic to the trial drug or any of its ingredients.
- People who currently have interstitial lung disease (a condition causing scarring or inflammation in the lungs).
- People who have active hepatitis B, hepatitis C, or HIV.
- Women who are pregnant or breastfeeding.
- People who have a neurological or psychiatric condition that would make it difficult to cooperate with the study.
- People who are already taking part in another clinical treatment study.
- People who the trial doctors consider unsuitable for any other reason (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 02165115006
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
3-year event-free survival (EFS) rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.